Topics

Articles

A looming crisis in drug-resistant anti-infectives is not being met with a commensurate industry effort. Governments and industry are trying to cope

The Struggle to Get Anti-Infectives on a Faster Track to Commercialization

As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy

Rare Diseases and Orphan Drugs Lift Pharma Innovation

The 2010 PDMA Sharing Conference: Expanding Our Focus With More Learning Opportunities

PDMA 2010: The Power of Sharing

Industry’s coming challenges will force dramatic change on how products are brought to market and businesses are sustained. Industry leaders have already started the process

The Drive to Develop New Commercial Models

Faced with fierce competition, dwindling budgets and intense pressure to create jobs, economic development authorities are reinventing their recruitment strategies to attract life sciences employers

Site Selection 2010: Development Authorities Recalibrate Their Pitch as Biopharma Growth Slowly Rebounds

Optimization of 2-8 Degrees Celsius Controlled-Temperature Small Parcels

Patient Outcomes Research Moves Drug Development Beyond Clinical Results

‘Print on demand’ changes traditional design, production and inventory practices for labels, inserts and other printed packaging

Pharma Gets a 'Just in Time' Speedup With the Switch to Digital Printing

While nurses move into a more central role in prescribing and administering pharmaceuticals, the nursing professions debate industry influence

Putting Nursing Into the Pharmaceutical Usage Equation

As legislative mandates have receded, manufacturers must undertake their own initiatives for protecting against counterfeits and diversion

Brand & Product Security